Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same
申请人:KAKEN PHARMACEUTICAL CO., LTD.
公开号:EP0291007A1
公开(公告)日:1988-11-17
A rhodanine derivative having the formula (I):
wherein R is a branched alkyl group having 5 to 7 carbon atoms or a cycloalkylalkyl group having 5 to 7 carbon atoms which may be substituted by a halogen atom; or a nontoxic salt thereof. The rhodanine derivatives (I) and their nontoxic salts have excellent aldose reductase inhibiting activity and low toxicity, and therefore can be used as therapeutic agent for diabetic complications.
一种具有以下化学式(I)的罗丹啉衍生物:其中R是具有5到7个碳原子的支链烷基基团或具有5到7个碳原子的环烷基烷基基团,可能被卤原子取代;或其无毒盐。这些罗丹啉衍生物(I)及其无毒盐具有出色的醛糖还原酶抑制活性和低毒性,因此可用作治疗糖尿病并发症的药物。